ValiRx plc (LON:VAL – Get Free Report)’s share price fell 7.1% during trading on Tuesday . The company traded as low as GBX 0.35 and last traded at GBX 0.35. 263,184 shares traded hands during trading, a decline of 96% from the average session volume of 7,443,810 shares. The stock had previously closed at GBX 0.38.
ValiRx Price Performance
The firm has a 50-day simple moving average of GBX 0.35 and a 200-day simple moving average of GBX 0.51. The firm has a market capitalization of £2.67 million, a PE ratio of -0.39 and a beta of 0.59. The company has a debt-to-equity ratio of 0.44, a current ratio of 6.65 and a quick ratio of 1.27.
ValiRx (LON:VAL – Get Free Report) last released its quarterly earnings results on Monday, September 29th. The company reported GBX (0.22) EPS for the quarter. ValiRx had a negative net margin of 20,554.01% and a negative return on equity of 55.84%. As a group, equities analysts forecast that ValiRx plc will post -1.74 earnings per share for the current year.
ValiRx Company Profile
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Featured Stories
- Five stocks we like better than ValiRx
- Do not delete, read immediately
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- Can Any Expenses Be Deducted From Capital Gains Tax?
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- Forget AI, This Will Be the Next Big Tech Breakthrough
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
